The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Personalized organoids — ‘mini-organs’ — may accelerate treatment for patients with rare genetic disorders. Courtesy of Europeana via Unsplash Across the globe, countless babies ...
Jan. 31, 2025 – The FDA has approved a new non-opioid oral drug for acute pain in adults. It is the first new class of non-opioid pain medicine approved in over 20 years, providing effective ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
In a statement, Dr. Jacqueline Corrigan-Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, called the approval ... care and pain medicine at NYU Grossman School ...